Table 4 Adjusted risk ratios of allergic conditions associated with a twofold increase in prenatal phthalates and bisphenols.
Asthma | Wheeze | |||||
|---|---|---|---|---|---|---|
Cohorts | N | RR (95%CI) | Cohorts | N | RR (95%CI) | |
DMP | 4 | 1927 | 0.97 (0.92–1.04) | 4 | 1983 | 1.00 (0.96–1.04) |
DEP | 8 | 2900 | 1.02 (0.98–1.07) | 10 | 3447 | 1.00 (0.98–1.03) |
DBP | 8 | 2900 | 1.08 (1.00–1.16) | 10 | 3447 | 1.04 (1.00–1.08) |
BBzP | 8 | 2900 | 1.06 (1.00–1.12) | 10 | 3447 | 1.01 (0.99–1.04) |
DEHP | 8 | 2900 | 1.00 (0.94–1.07) | 10 | 3447 | 1.01 (0.97–1.04) |
MCPP | 7 | 2812 | 1.02 (0.97–1.08) | 9 | 3344 | 1.03 (1.00–1.05) |
BPA | 7 | 2163 | 0.99 (0.95–1.05) | 9 | 2710 | 1.00 (0.97–1.02) |
BPS | 5 | 1808 | 0.98 (0.93–1.03) | 7 | 2231 | 1.00 (0.97–1.03) |
BPF | 4 | 1570 | 1.03 (0.99–1.07) | 6 | 1993 | 1.00 (0.98–1.02) |
Eczema | Rhinitis | |||||
|---|---|---|---|---|---|---|
Cohorts | N | RR (95%CI) | Cohorts | N | RR (95%CI) | |
DMP | 4 | 1947 | 0.98 (0.95–1.02) | 4 | 1869 | 1.01 (0.96–1.05) |
DEP | 9 | 3111 | 1.02 (0.99–1.04) | 8 | 2562 | 1.00 (0.98–1.03) |
DBP | 9 | 3111 | 1.01 (0.97–1.04) | 8 | 2562 | 1.01 (0.97–1.05) |
BBzP | 9 | 3111 | 1.00 (0.97–1.03) | 8 | 2562 | 1.01 (0.97–1.04) |
DEHP | 9 | 3111 | 0.97 (0.93–1.00) | 8 | 2562 | 1.03 (0.99–1.07) |
MCPP | 8 | 3023 | 1.03 (0.99–1.06) | 7 | 2474 | 1.05 (1.01–1.09) |
BPA | 8 | 2409 | 0.99 (0.96–1.02) | 7 | 1860 | 1.01 (0.97–1.05) |
BPS | 6 | 1945 | 0.98 (0.94–1.01) | 5 | 1396 | 1.01 (0.96–1.05) |
BPF | 5 | 1707 | 1.01 (0.98–1.04) | 4 | 1158 | 1.03 (0.99–1.07) |
